Discovery of novel, PD-L1-independent immune checkpoints using JEDI GFP-specific CD8 T cells.

3076Background: Checkpoint blockade has emerged as an effective strategy for enhancing the endogenous T cell response against tumor-associated antigens. Its clinical benefit is maximized when combi...